CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

Turning a $10,000 investment into $1 million represents a financial dream for many — a 100x return that would require an ...

Eli Lilly has struck a deal to buy Crispr gene-editing start-up Verve Therapeutics for up to $1.3bn, the latest acquisition ...

Japanese researchers have successfully eliminated the extra chromosome responsible for Down syndrome using CRISPR gene ...

For decades, researchers have wondered why some people with risky gene variants go on to develop Parkinson’s disease, while ...

A team at Kobe University has created a game-changing resource for autism research: 63 mouse embryonic stem cell lines, each ...

Crispr Therapeutics AG leverages CASGEVY's rollout, a robust pipeline in cardiovascular, oncology, & partnerships to large ...

CRISPR Gene editing therapy is used for the first time in living humans with amazing results.

Brian Armstrong, the billionaire CEO of the cryptocurrency exchange Coinbase, says he’s ready to fund a US startup focused on ...

Amid a challenging gene editing climate, partnerships between researchers, regulators, and industry remain crucial for ...